{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:31:00Z","timestamp":1791307860644,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pusan National University (KR)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12272-016-0802-0","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T03:11:58Z","timestamp":1469675518000},"page":"1160-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Mi Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Moon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Ra","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"802_CR1","doi-asserted-by":"crossref","first-page":"e61700","DOI":"10.1371\/journal.pone.0061700","volume":"8","author":"D Alvarez-Fischer","year":"2013","unstructured":"Alvarez-Fischer D, Noelker C, Vulinovic F, Grunewald A, Chevarin C, Klein C, Oertel WH, Hirsch EC, Michel PP, Hartmann A (2013) Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PLoS One 8:e61700","journal-title":"PLoS One"},{"key":"802_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0006-8993(01)02466-0","volume":"905","author":"DW Anderson","year":"2001","unstructured":"Anderson DW, Neavin T, Smith JA, Schneider JS (2001) Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res 905:44\u201353","journal-title":"Brain Res"},{"key":"802_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(98)00307-4","volume":"163","author":"JP Bennett Jr","year":"1999","unstructured":"Bennett JP Jr, Piercey MF (1999) Pramipexole-a new dopamine agonist for the treatment of Parkinson\u2019s disease. J Neurol Sci 163:25\u201331","journal-title":"J Neurol Sci"},{"key":"802_CR4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini F, Armentero MT (2012) Animal models of Parkinson\u2019s disease. FEBS J 279:1156\u20131166","journal-title":"FEBS J"},{"key":"802_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0361-9230(94)00242-S","volume":"36","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR (1995) Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats. Brain Res Bull 36:549\u2013556","journal-title":"Brain Res Bull"},{"key":"802_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.parkreldis.2012.04.030","volume":"18","author":"SY Cho","year":"2012","unstructured":"Cho SY, Shim SR, Rhee HY, Park HJ, Jung WS, Moon SK, Park JM, Ko CN, Cho KH, Park SU (2012) Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 18:948\u2013952","journal-title":"Parkinsonism Relat Disord"},{"key":"802_CR7","first-page":"S21","volume":"54","author":"MC Rijk De","year":"2000","unstructured":"De Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson\u2019s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 54:S21\u2013S23","journal-title":"Neurologic Diseases in the Elderly Research Group Neurology"},{"issue":"Suppl 1","key":"802_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1179\/016164109X12537002794282","volume":"32","author":"AR Doo","year":"2010","unstructured":"Doo AR, Kim ST, Kim SN, Moon W, Yin CS, Chae Y, Park HK, Lee H, Park HJ (2010) Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson\u2019s disease. Neurol Res 32(Suppl 1):88\u201391","journal-title":"Neurol Res"},{"key":"802_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnana.2015.00032","volume":"9","author":"MT Herrero","year":"2015","unstructured":"Herrero MT, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson\u2019s disease: role of glucocorticoids. Front Neuroanat 9:32","journal-title":"Front Neuroanat"},{"key":"802_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxicon.2005.03.015","volume":"46","author":"SJ Hong","year":"2005","unstructured":"Hong SJ, Rim GS, Yang HI, Yin CS, Koh HG, Jang MH, Kim CJ, Choe BK, Chung JH (2005) Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 46:39\u201345","journal-title":"Toxicon"},{"key":"802_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jep.2005.02.026","volume":"99","author":"HS Jang","year":"2005","unstructured":"Jang HS, Kim SK, Han JB, Ahn HJ, Bae H, Min BI (2005) Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. J Ethnopharmacol 99:157\u2013160","journal-title":"J Ethnopharmacol"},{"key":"802_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7007-2-22","volume":"2","author":"JN Joyce","year":"2004","unstructured":"Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D (2004) Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson\u2019s disease, and downregulates the dopamine transporter via the D3 receptor. BMC Biol 2:22","journal-title":"BMC Biol"},{"key":"802_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuint.2014.11.008","volume":"80","author":"WK Khalil","year":"2015","unstructured":"Khalil WK, Assaf N, Elshebiney SA, Salem NA (2015) Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem Int 80:79\u201386","journal-title":"Neurochem Int"},{"key":"802_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/00207454.2010.548613","volume":"121","author":"JI Kim","year":"2011","unstructured":"Kim JI, Yang EJ, Lee MS, Kim YS, Huh Y, Cho IH, Kang S, Koh HK (2011) Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson\u2019s disease. Int J Neurosci 121:209\u2013217","journal-title":"Int J Neurosci"},{"key":"802_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1992.tb24527.x","volume":"648","author":"IJ Kopin","year":"1992","unstructured":"Kopin IJ (1992) Features of the dopaminergic neurotoxin MPTP. Ann N Y Acad Sci 648:96\u2013104","journal-title":"Ann N Y Acad Sci"},{"key":"802_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(02)01617-X","volume":"71","author":"YB Kwon","year":"2002","unstructured":"Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, Beitz AJ, Lee JH (2002) The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci 71:191\u2013204","journal-title":"Life Sci"},{"key":"802_CR17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","volume":"33","author":"YJ Lee","year":"2010","unstructured":"Lee YJ, Han SB, Nam SY, Oh KW, Hong JT (2010) Inflammation and Alzheimer\u2019s disease. Arch Pharm Res 33:1539\u20131556","journal-title":"Arch Pharm Res"},{"key":"802_CR18","first-page":"7","volume":"15","author":"SH Lee","year":"2012","unstructured":"Lee SH, Kwon GS, Kang MS, Yoon HM, Kim CH (2012) Comparative study on the effects of bee venom pharmacopuncture according to the treatment method for knee osteoarthritis. J Pharmacopuncture 15:7\u201314","journal-title":"J Pharmacopuncture"},{"key":"802_CR19","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/toxins7082835","volume":"7","author":"SH Lee","year":"2015","unstructured":"Lee SH, Choi SM, Yang EJ (2015) Bee venom acupuncture augments anti-inflammation in the peripheral organs of hSOD1G93A transgenic mice. Toxins (Basel) 7:2835\u20132844","journal-title":"Toxins (Basel)"},{"key":"802_CR20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354\u2013365","journal-title":"Neurotherapeutics"},{"key":"802_CR21","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","volume":"2","author":"J Massano","year":"2012","unstructured":"Massano J, Bhatia KP (2012) Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2:a008870","journal-title":"Cold Spring Harb Perspect Med"},{"key":"802_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpba.2010.08.020","volume":"54","author":"J Matysiak","year":"2011","unstructured":"Matysiak J, Schmelzer CE, Neubert RH, Kokot ZJ (2011) Characterization of honeybee venom by MALDI-TOF and nanoESI-QqTOF mass spectrometry. J Pharm Biomed Anal 54:273\u2013278","journal-title":"J Pharm Biomed Anal"},{"key":"802_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(92)90024-X","volume":"215","author":"J Mierau","year":"1992","unstructured":"Mierau J, Schingnitz G (1992) Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur J Pharmacol 215:161\u2013170","journal-title":"Eur J Pharmacol"},{"key":"802_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2007.05.002","volume":"53","author":"A Mirshafiey","year":"2007","unstructured":"Mirshafiey A (2007) Venom therapy in multiple sclerosis. Neuropharmacology 53:353\u2013361","journal-title":"Neuropharmacology"},{"key":"802_CR25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.intimp.2007.04.005","volume":"7","author":"DO Moon","year":"2007","unstructured":"Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY (2007) Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7:1092\u20131101","journal-title":"Int Immunopharmacol"},{"key":"802_CR26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.rvsc.2011.08.007","volume":"93","author":"HO Nisbet","year":"2012","unstructured":"Nisbet HO, Ozak A, Yardimci C, Nisbet C, Yarim M, Bayrak IK, Sirin YS (2012) Evaluation of bee venom and hyaluronic acid in the intra-articular treatment of osteoarthritis in an experimental rabbit model. Res Vet Sci 93:488\u2013493","journal-title":"Res Vet Sci"},{"issue":"Suppl 2","key":"802_CR27","first-page":"II51","volume":"247","author":"O Rascol","year":"2000","unstructured":"Rascol O (2000) The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson\u2019s disease. J Neurol 247(Suppl 2):II51\u2013II57","journal-title":"J Neurol"},{"key":"802_CR28","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1242\/dev.126.18.4017","volume":"126","author":"K Sakurada","year":"1999","unstructured":"Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126:4017\u20134026","journal-title":"Development"},{"issue":"Suppl 3","key":"802_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-1331.9.s3.9.x","volume":"9","author":"AH Schapira","year":"2002","unstructured":"Schapira AH (2002a) Dopamine agonists and neuroprotection in Parkinson\u2019s disease. Eur J Neurol 9(Suppl 3):7\u201314","journal-title":"Eur J Neurol"},{"key":"802_CR30","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.suppl_1.S9","volume":"58","author":"AH Schapira","year":"2002","unstructured":"Schapira AH (2002b) Neuroprotection and dopamine agonists. Neurology 58:S9\u2013S18","journal-title":"Neurology"},{"key":"802_CR31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.2009.06381.x","volume":"111","author":"JY Shin","year":"2009","unstructured":"Shin JY, Park HJ, Ahn YH, Lee PH (2009) Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson\u2019s disease: a direct comparison study. J Neurochem 111:1042\u20131050","journal-title":"J Neurochem"},{"key":"802_CR32","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.3390\/toxins7083179","volume":"7","author":"J Silva","year":"2015","unstructured":"Silva J, Monge-Fuentes V, Gomes F, Lopes K, Dos Anjos L, Campos G, Arenas C, Biolchi A, Goncalves J, Galante P, Campos L, Mortari M (2015) Pharmacological alternatives for the treatment of neurodegenerative disorders: wasp and bee venoms and their components as new neuroactive tools. Toxins (Basel) 7:3179\u20133209","journal-title":"Toxins (Basel)"},{"key":"802_CR33","first-page":"1878","volume":"15","author":"SD Somerfield","year":"1988","unstructured":"Somerfield SD, Brandwein S (1988) Bee venom and adjuvant arthritis. J Rheumatol 15:1878","journal-title":"J Rheumatol"},{"key":"802_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pharmthera.2007.04.004","volume":"115","author":"DJ Son","year":"2007","unstructured":"Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT (2007) Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 115:246\u2013270","journal-title":"Pharmacol Ther"},{"key":"802_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jnnp.46.2.145","volume":"46","author":"Y Stern","year":"1983","unstructured":"Stern Y, Mayeux R, Rosen J, Ilson J (1983) Perceptual motor dysfunction in Parkinson\u2019s disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry 46:145\u2013151","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"802_CR36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","volume":"318","author":"P Teismann","year":"2004","unstructured":"Teismann P, Schulz JB (2004) Cellular pathology of Parkinson\u2019s disease: astrocytes, microglia and inflammation. Cell Tissue Res 318:149\u2013161","journal-title":"Cell Tissue Res"},{"key":"802_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","volume":"88","author":"KU Tufekci","year":"2012","unstructured":"Tufekci KU, Meuwissen R, Genc S, Genc K (2012) Inflammation in Parkinson\u2019s disease. Adv Protein Chem Struct Biol 88:69\u2013132","journal-title":"Adv Protein Chem Struct Biol"},{"key":"802_CR38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1073858403259282","volume":"9","author":"T Tzounopoulos","year":"2003","unstructured":"Tzounopoulos T, Stackman R (2003) Enhancing synaptic plasticity and memory: a role for small-conductance Ca2+-activated K+ channels. Neuroscientist 9:434\u2013439","journal-title":"Neuroscientist"},{"key":"802_CR39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nurt.2010.05.012","volume":"7","author":"MR Vargas","year":"2010","unstructured":"Vargas MR, Johnson JA (2010) Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics 7:471\u2013481","journal-title":"Neurotherapeutics"},{"key":"802_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19","journal-title":"Transl Neurodegener"},{"key":"802_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1742-2094-7-69","volume":"7","author":"EJ Yang","year":"2010","unstructured":"Yang EJ, Jiang JH, Lee SM, Yang SC, Hwang HS, Lee MS, Choi SM (2010) Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflamm 7:69","journal-title":"J Neuroinflamm"},{"key":"802_CR42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1742-2094-8-69","volume":"8","author":"EJ Yang","year":"2011","unstructured":"Yang EJ, Kim SH, Yang SC, Lee SM, Choi SM (2011) Melittin restores proteasome function in an animal model of ALS. J Neuroinflamm 8:69","journal-title":"J Neuroinflamm"},{"issue":"Suppl 1","key":"802_CR43","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S1353-8020(11)70066-9","volume":"18","author":"F Zhang","year":"2012","unstructured":"Zhang F, Zhou H, Wilson BC, Shi JS, Hong JS, Gao HM (2012) Fluoxetine protects neurons against microglial activation-mediated neurotoxicity. Parkinsonism Relat Disord 18(Suppl 1):S213\u2013S217","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-016-0802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-016-0802-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-016-0802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:22:47Z","timestamp":1656894167000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-016-0802-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1007\/s12272-016-0802-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}